GlobalData on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Minaris and Genetix Biotherapeutics have expanded their manufacturing partnership to increase commercial-scale production of ...
News-Medical.Net on MSN
Study shows biosynthetic method to make low-calorie sugar substitute
From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback